Neovasc Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products and clinical research.
The company stated in the following article that they conduct pre-clinical trials of their drugs on animals.
“The Neovasc Tiara is a prosthetic mitral valve being developed to treat mitral regurgitation. Using transcatheter mitral valve implantation (TMVI) methodology, this mitral heart valve is currently in animal trials with first-in-man planned for 2013.” Read the following article
Neovasc, Inc. operates as a medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular device marketplace. Its products include the Neovasc Reducer for the treatment of refractory angina and the Tiara technology in development for the transcatheter treatment of mitral valve disease. It operates through the following geographical segments: U.S., Europe, and the Rest of the World. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada. [Source: MarketWatch]
Company Website: http://www.neovasc.com